Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

New Approaches to Modifying Inotropy in Sepsis-Induced Myocardial Dysfunction*

Walley, Keith R. MD

doi: 10.1097/CCM.0000000000002126

Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada

*See also p. e391.

Supported, in part, by a grant from Canadian Institutes for Health Research. Dr. Walley’s institution received funding from Canadian Institutes for Health Research. He disclosed that he is a founder and shareholder of Cyon Therapeutics.

Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.